XML 33 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed consolidated and combined statements of cash flows (USD $)
3 Months Ended 123 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Operating activities      
Net loss and comprehensive loss incurred in the development stage $ (4,227,678) $ (1,010,267) $ (51,502,587)
Non-cash items and reclassifications:      
Amortization 18,238 14,785 629,410
Financing costs 319,635   333,877
Fees and penalty on bank loan repayment 100,000   100,000
Gain on sale of equipment   (29,396) (134,553)
Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock 1,884,233 25,438 2,395,575
Change in fair value of derivative liabilities (913,929)   (2,102,193)
Stock-based compensation 137,654 54,674 1,409,722
Foreign exchange loss 106,501   106,501
Change in non-cash working capital:      
Accounts and other amounts receivable (38,580) (170) (66,524)
Prepayments and deposits (453,705) 10,480 (626,223)
Accounts payable and accrued liabilities (734,537) 37,835 854,211
Cash used in operating activities (3,802,168) (896,621) (48,602,784)
Investing activities      
Purchase of short-term investments     (2,820,600)
Purchase of property and equipment (4,463) (4,696) (549,003)
Sale of property and equipment   50,810 191,817
Purchase of intangible assets     (183,629)
Cash (used in) provided by investing activities (4,463) 46,114 (3,361,415)
Financing activities      
Repayment of bank loan, fees and penalty (2,600,000)   (100,000)
Loan costs     (107,911)
Issuance of promissory notes     720,863
Repayment of promissory notes     (255,775)
Common stock issued     490,176
Repurchase of common stock     (350)
Preferred stock (redemption) issued (491) 17,999,961 57,835,418
Special voting common stock issued   7 44
Share issue costs   (132,748) (1,431,558)
Initial public offering of common shares 53,130,000   53,130,000
Initial public offering costs (4,810,943)   (5,398,381)
Cash provided by financing activities 45,718,566 17,867,220 104,882,526
Increase in cash and cash equivalents during the period 41,911,935 17,016,713 52,918,327
Cash and cash equivalents, beginning of period 11,006,392 2,000,539  
Cash and cash equivalents, end of period 52,918,327 19,017,252 52,918,327
Supplemental disclosure of cash flow information:      
Interest paid 31,719   31,719
Investing activities      
Purchase of intangible assets for shares issued     44,834
Financing activities      
Accrued offering costs $ 390,345   $ 390,345